CVRX logo

CVRX INC

CVRXNASDAQ
🏆 #4296 by market capUS Equity
$542.22▲ $30.53 (+5.63%)
Simulated price
🔔
Track CVRX
Get earnings, price moves & breaking news on Telegram
Track
24h▲ 5.6%
7d—
14d—
30d—
ytd—
1y—
🏦Market Cap
$69M
Small Cap
📈Revenue Growth (YoY)
+10.4%
Healthy
📊Gross Margin
86.6%
High
💵FCF Margin
-67.1%
Thin
⚖️P/S Ratio
1.1x
Cheap
Otter Score
64
Fair
No chart data available for CVRX.

Trading Snapshot

Day Range
$533.92 – $551.46
52-Week Range
$2.20 – $11.30
Volume
$2.64B
Avg Volume
$3.10B
Shares Outstanding
26.5M
Next Earnings
Dec 8, 2026

Fundamentals Snapshot

Annual Revenue
$57M
Last Q Revenue
$16M
P/E Ratio
-1.3
P/S Ratio
1.1x
EPS (TTM)
$-1.96
Dividend Yield
0.00%
Dilution (1yr)
+16.0%

Why Investors Own CVRX

  • ✓High-growth profile — revenue up +22.1% YoY with expanding US Equity exposure.
  • ✓Healthy economics — 80% gross margin and 11% free-cash-flow margin.
  • ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

CVRX logo

CVRX INC

CVRX
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$57M▲ +10.4% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
85.3%▲ +1.9% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$51M▼ −13.8% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$41M▲ +0.6% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
26.2M▲ +16.0% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$25M▼ −$31M YoY
StockOtter · stockotter.space

About CVRX INC

CVRx, Inc. is a commercial-stage medical technology company focused on innovating, producing, and bringing to market neuromodulation solutions designed for individuals battling cardiovascular diseases. Its principal offering, Barostim, is an advanced neuromodulation device specifically indicated to ameliorate symptoms for patients diagnosed with heart failure characterized by reduced ejection fraction, often referred to as systolic heart failure. The company employs a diverse distribution strategy, leveraging its internal sales force, alongside sales agents and independent distributors, to reach markets across the United States, Germany, the wider European continent, and other global territories. Incorporated in 2000, CVRx, Inc. is headquartered in Minneapolis, Minnesota.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Fair
64/100

Analyst Price Target

ⓘ
Average Target
$550.74
▲ +1.6% Upside
High Target$624.18
Low Target$448.72
Based on 30 analysts

Latest News & Updates

🚀
CNBC·2h ago

CVRX INC tops quarterly estimates as demand accelerates

Revenue grew double digits with management guiding above consensus; margins continued to expand.

🛰️
MarketWatch·5h ago

Analysts lift CVRX price targets on improving margins

Several firms raised targets, citing stronger free cash flow and a healthier backlog.

🌌
Bloomberg·1d ago

CVRX INC announces new agreement to expand its footprint

The move broadens the company’s reach and could add incremental revenue over the next year.